Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists.
Charles Gauthier(Université du Québec à Chicoutimi), Hervé Le Marec(Centre National de la Recherche Scientifique), Jean‐Noël Trochu, Dominique Langin(Université Toulouse III - Paul Sabatier), Véronique Leblais(Inserm), D. F. Escande(Centre National de la Recherche Scientifique), K. Laurent, Geneviève Tavernier(Université Toulouse III - Paul Sabatier)
PubMed
August 1, 1999
Cited by 88
Related Papers
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
|Heart Rhythm|2011|1.5k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death
|Nature|2003|961
Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome
|Circulation|2010|850